The Center for Surgical, Medical Acute Care Research and Transitions (C-SMART), Birmingham Veterans Administration Hospital, Birmingham, AL; Section of Gastrointestinal Surgery, Department of Surgery, University of Alabama at Birmingham, Birmingham, AL.
J Am Coll Surg. 2013 Nov;217(5):763-9. doi: 10.1016/j.jamcollsurg.2013.07.003. Epub 2013 Sep 14.
The Surgical Care Improvement Program endorses mandatory compliance with approved intravenous prophylactic antibiotics; however, oral antibiotics are optional. We hypothesized that surgical site infection (SSI) rates may vary depending on the choice of antibiotic prophylaxis.
A retrospective cohort study of elective colorectal procedures using Veterans Affairs Surgical Quality Improvement Program (VASQIP) and SSI outcomes data was linked to the Office of Informatics and Analytics (OIA) and Pharmacy Benefits Management (PBM) antibiotic data from 2005 to 2009. Surgical site infection rates by type of IV antibiotic agent alone (IV) or in combination with oral antibiotic (IV + OA) were determined. Generalized estimating equations were used to examine the association between type of antibiotic prophylaxis and SSI for the entire cohort and stratified by use of oral antibiotics.
After 5,750 elective colorectal procedures, 709 SSIs (12.3%) developed within 30 days. Oral antibiotic + IV (n = 2,426) had a lower SSI rate than IV alone (n = 3,324) (6.3% vs 16.7%, p < 0.0001). There was a significant difference in the SSI rate based on type of preoperative IV antibiotic given (p ≤ 0.0001). Generalized estimating equations adjusting for significant covariates of age, body mass index, procedure work relative value units, and operation duration demonstrated an independent protective effect of oral antibiotics (odds ratio [OR] 0.37, 95% CI 0.29 to 0.46), as well as increased rates of SSI associated with ampicillin/sulbactam (OR 2.21, 95% CI 1.37 to 3.56) and second generation cephalosporins (cefoxitin, OR 2.50, 95% CI 1.83 to 3.42; cefotetan, OR 2.70, 95% CI 1.72 to 4.22) when compared with first generation cephalosporin/metronidazole.
The choice of IV antibiotic was related to the SSI rate; however, oral antibiotics were associated with reduced SSI rate for every antibiotic class.
外科护理改进计划(Surgical Care Improvement Program)认可了静脉内预防性抗生素的强制性使用;然而,口服抗生素是可选的。我们假设,手术部位感染(Surgical Site Infection,SSI)的发生率可能因抗生素预防措施的选择而有所不同。
使用退伍军人事务部外科质量改进计划(Veterans Affairs Surgical Quality Improvement Program,VASQIP)和 SSI 结果数据进行回顾性队列研究,并将其与信息学和分析办公室(Office of Informatics and Analytics,OIA)和药房福利管理(Pharmacy Benefits Management,PBM)抗生素数据进行链接,时间范围为 2005 年至 2009 年。单独使用静脉内抗生素(IV)或与口服抗生素联合使用(IV+OA)的 IV 抗生素种类的 SSI 发生率。使用广义估计方程来检查整个队列中抗生素预防类型与 SSI 之间的关联,并根据口服抗生素的使用情况进行分层。
在 5750 例择期结直肠手术后,30 天内发生了 709 例 SSI(12.3%)。口服抗生素+IV(n=2426)的 SSI 发生率低于单独使用 IV(n=3324)(6.3% vs 16.7%,p<0.0001)。术前给予的 IV 抗生素种类存在显著的 SSI 发生率差异(p≤0.0001)。调整年龄、体重指数、手术相对价值单位和手术持续时间等显著协变量后,广义估计方程显示口服抗生素具有独立的保护作用(比值比[OR]0.37,95%置信区间[CI]0.29 至 0.46),以及与氨苄西林/舒巴坦(OR 2.21,95%CI 1.37 至 3.56)和第二代头孢菌素(头孢西丁,OR 2.50,95%CI 1.83 至 3.42;头孢替坦,OR 2.70,95%CI 1.72 至 4.22)相比,第一代头孢菌素/甲硝唑的 SSI 发生率增加。
IV 抗生素的选择与 SSI 发生率有关;然而,口服抗生素与每种抗生素类别相关的 SSI 发生率降低有关。